The Valley Desk

NCT02312206 · Interventional trial

The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis

Overall registry status Terminated

Phase 3

Conditions Primary Systemic (AL) Amyloidosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov